Baseline analysis, continuous factors. حسب Hiroaki Yoshikawa (4615801)

"…</p><p>Results</p><p>Our analysis revealed a significantly older age of onset in the 2018 cohort compared to 2006. …"

Multivariable analysis between 2006 and 2018. حسب Hiroaki Yoshikawa (4615801)

"…</p><p>Results</p><p>Our analysis revealed a significantly older age of onset in the 2018 cohort compared to 2006. …"

Original values used to build graphs. حسب Min Qin (123347)

"…The m⁶A-IP-qPCR assay further confirmed that <i>T. gondii</i> infection led to the decrease in the levels of m⁶A modification in the 3’UTR and 5’UTR regions of <i>TNF-α</i> mRNA. …"

Subject characteristics. حسب Barbara Mayr (7065950)

"…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…"

Raw data. حسب Barbara Mayr (7065950)

"…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…"

Flow diagram. حسب Barbara Mayr (7065950)

"…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…"

Data of Fig 4A. حسب Xianyu Piao (145967)

"…Among these five rSjCLs, only the immunization with rSjCL1 conferred partial protection to the mice against <i>S. japonicum</i> infection, resulting in a reduction in worm burden by 34.9% ~ 38.0% and a decrease of egg burden by 46.2% ~ 48.3%. …"

Image3_A novel functional IKBKE variant activating NFAT in a patient with polyarthritis and a remittent fever.jpeg حسب Saeko Yamada (11899439)

"…She had a poor response to corticosteroids or disease-modifying antirheumatic drugs, including the tumor necrosis factor-α antagonist, etanercept, and the anti-interleukin-6 receptor antibody, tocilizumab.…"

Image1_A novel functional IKBKE variant activating NFAT in a patient with polyarthritis and a remittent fever.jpeg حسب Saeko Yamada (11899439)

"…She had a poor response to corticosteroids or disease-modifying antirheumatic drugs, including the tumor necrosis factor-α antagonist, etanercept, and the anti-interleukin-6 receptor antibody, tocilizumab.…"

Image2_A novel functional IKBKE variant activating NFAT in a patient with polyarthritis and a remittent fever.jpeg حسب Saeko Yamada (11899439)

"…She had a poor response to corticosteroids or disease-modifying antirheumatic drugs, including the tumor necrosis factor-α antagonist, etanercept, and the anti-interleukin-6 receptor antibody, tocilizumab.…"

The category of PAL [65]. حسب Juntong Lai (21464598)

"…The minimum damage leading to persistent inflammation is decreased as BMI increases and the correlation is nonlinear, which suggests a significant rise in OA risk with a high level of obesity. …"

The description of dimensional parameters. حسب Juntong Lai (21464598)

"…The minimum damage leading to persistent inflammation is decreased as BMI increases and the correlation is nonlinear, which suggests a significant rise in OA risk with a high level of obesity. …"

The formula of parameter nondimensionalisation. حسب Juntong Lai (21464598)

"…The minimum damage leading to persistent inflammation is decreased as BMI increases and the correlation is nonlinear, which suggests a significant rise in OA risk with a high level of obesity. …"

Primers used in RT-qPCR. حسب Changwen Ning (15071847)

"…LBH589, a pan-histone deacetylase inhibitor, exhibits promising anti-inflammatory and immunomodulatory properties. …"

DataSheet1_A novel functional IKBKE variant activating NFAT in a patient with polyarthritis and a remittent fever.docx حسب Saeko Yamada (11899439)

"…She had a poor response to corticosteroids or disease-modifying antirheumatic drugs, including the tumor necrosis factor-α antagonist, etanercept, and the anti-interleukin-6 receptor antibody, tocilizumab.…"

Table 2_A comprehensive and systematic review on resveratrol supplementation as a promising candidate for the retinal disease: a focus on mechanisms of action from preclinical stud... حسب Xiao-Min Lv (21575681)

"…Background<p>Resveratrol is a natural polyphenolic compound that shows great potential in neuroprotection, anti-inflammation,and antioxidation. …"

Table 1_A comprehensive and systematic review on resveratrol supplementation as a promising candidate for the retinal disease: a focus on mechanisms of action from preclinical stud... حسب Xiao-Min Lv (21575681)

"…Background<p>Resveratrol is a natural polyphenolic compound that shows great potential in neuroprotection, anti-inflammation,and antioxidation. …"

Supporting datasets for all figures. حسب Matthew Drill (22258391)

"…Inhibition of P2X7R with small molecule antagonist AZ10606120, for 72 hours significantly decreased U251 cell number (p < 0.0001), and significantly increased tumour cell death, as evidenced by increased LDH release (p < 0.001). …"

qorA associated data حسب fengning chen (20930834)

"…Notably, the <i>qorA</i> mutant exhibited impaired survival against neutrophil killing as well as reduced viability in human blood, plasma, and during mouse bloodstream infections, along with a significant decline in its anti-phagocytic capability. …"

MDSC inhibition was correlated with Trp metabolism in 17ZR101-infected lungs. حسب Qi Xu (134661)

"…<p>C57BL/6 mice were inoculated with 10⁴ CFU of hv<i>Kp</i> strain 17ZR101 intravenously and the Gr-1⁺ cells were isolated at 12 hpi for T cell inhibition analysis. (a) CFSE-labeled normal spleen T cells were stimulated with immobilized anti-CD3e and anti-CD28 mAb for 3 days in the presence of Gr-1⁺ cells (ratio: 1:1, 1:2, 1:4 and 1:16). …"